{"id":"NCT00754065","sponsor":"Bayer","briefTitle":"To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)","officialTitle":"A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Group, 2-arm Study to Show Superiority of the Oral Contraceptive SH T00658ID Over Ortho Tri-Cyclen Lo on Hormone Withdrawal-associated Symptoms After 6 Cycles of Treatment.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-09-08","primaryCompletion":"2011-05-10","completion":"2011-05-10","firstPosted":"2008-09-17","resultsPosted":"2012-08-28","lastUpdate":"2024-11-20"},"enrollment":409,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Contraception"],"interventions":[{"type":"DRUG","name":"Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027)","otherNames":[]},{"type":"DRUG","name":"Ortho Tri Cyclen Lo","otherNames":[]}],"arms":[{"label":"Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027)","type":"EXPERIMENTAL"},{"label":"Ortho Tri-Cyclen Lo","type":"ACTIVE_COMPARATOR"}],"summary":"The objective of the study is to compare the oral contraceptive (OC) SH T00658ID over Ortho Tri-Cyclen Lo administered for 13 cycles to healthy female volunteers between 18 and 50 years of age who request oral contraceptive protection. Subjects on a levonorgestrel (LNG), norgestimate (NGM), norethindrone or norethindrone acetate containing oral contraceptive in a 21-day regimen suffering from hormone withdrawal-associated symptoms such as pelvic pain or headache or both, and willing to continue OC use but to switch to SH T00658ID or Ortho Tri-Cyclen Lo.","primaryOutcome":{"measure":"The Change in Average of the 3 Highest Visual Analog Scale (VAS) Values of the Hormone Withdrawal-associated Symptoms Pelvic Pain or Headache During Cycle Days 22 to 28 From Baseline to Cycle 6","timeFrame":"Day 22-28 from Baseline to Day 22-28 from Cycle 6 (28 days per Cycle)","effectByArm":[{"arm":"Estradiol Valerate, Dienogest (Natazia, Qlaira, BAY86-5027)","deltaMin":43.05,"sd":23.58},{"arm":"Ortho Tri-Cyclen Lo","deltaMin":34.97,"sd":25.9}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0024"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":59,"countries":["United States","Canada"]},"refs":{"pmids":["23638631"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":191},"commonTop":["Headache","Pelvic pain","Abdominal distension","Nausea","Metrorrhagia"]}}